W. Alberto Sifuentes Giraldo: An Overview of Thrombotic Risk and Diagnostic Criteria in Antiphospholipid Syndrome
W. Alberto Sifuentes Giraldo, Rheumatologist at Hospital Nuestra Señora de Sonsoles (Sacyl), shared a post on X:
“Antiphospholipid Syndrome
Rare systemic autoimmune disease (prevalence: 50 per 100,000 in females and 9.8 per 100,000 in males) responsible for thrombotic events and obstetric morbidity in individuals with persistent antiphospholipid autoantibodies:
- anticardiolipin antibodies IgG or IgM
- anti-β2-glycoprotein-I antibodies IgG or IgM
- lupus anticoagulants
It is a leading cause of acquired thrombophilia, accounting for 10 percent of arterial or venous thrombosis.
These thrombotic events can lead to acute organ dysfunction or failure, sometimes requiring intensive care unit admission, or can even escalate into a ‘thrombotic storm’ called the catastrophic antiphospholipid syndrome.
Classification criteria for antiphospholipid syndrome have very been updated in 2023 by the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR).
These criteria are applicable to patients with at least one positive laboratory test within 3 years of a clinical manifestation.
Clinical manifestation of antiphospholipid syndrome.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn Ruksakulpiwat։ A New Milestone in the Development of the Stroke Risk Screening Scales
-
Aug 10, 2026, 16:09Preetie Shetty Akkunje: Making Stroke Rehabilitation Accessible in Low-Resource Settings
-
Aug 10, 2026, 15:50The Next Antithrombotic Frontier: GPVI Inhibitors Beyond Aspirin